A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : cCR / complete clinical response

[Related PubMed/MEDLINE]
Total Number of Papers: 78
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   cCR  (>> Co-occurring Abbreviation)
Long Form:   complete clinical response
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Impact of clinical complete response on treatment outcomes in patients with locally advanced HPV-negative oropharyngeal squamous cell carcinoma. CRT, HPV, OPSCC, S-IMRT, SIB-IMRT
2020 Radiotherapy of primary cutaneous anaplastic large cell lymphoma: our experience in 30 cases. pcALCL, PCR, RT
2020 The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases. CPR, LE, NPV, OG, PPV, TME, TNT, TNT
2020 [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report]. LALRC, nCRT, near-cCR, TNT
2019 Clinical Complete Response after Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Call for Standardized Assessments and Definitions. NAC
2019 Clinical outcome of HCV-associated cryoglobulinemic glomerulonephritis following treatment with direct acting antiviral agents: a case-based review. CC, DAAs, HCV, HCV-GN, IS, SVR
2019 Clinical Response to Induction Chemotherapy Predicts Outcome after Combined-Modality Therapy in Inflammatory Breast Cancer. DFS, IBC, LC, OS
2019 Conditional Survival in Patients With Rectal Cancer and Complete Clinical Response Managed by Watch and Wait After Chemoradiation: Recurrence Risk Over Time. CRFS, nCRT, RFS
2019 How Is Rectal Cancer Managed: a Survey Exploring Current Practice Patterns in Canada. TAMIS, TaTME, TEMs
10  2019 Image Guided Adaptive Endorectal Brachytherapy in the Nonoperative Management of Patients With Rectal Cancer. ---
11  2019 Nonoperative management after neoadjuvant therapy for rectal cancer: A single institution experience over 5 years. ---
12  2019 Organ Preservation in cT2N0 Rectal Cancer After Neoadjuvant Chemoradiation Therapy: The Impact of Radiation Therapy Dose-escalation and Consolidation Chemotherapy. CRT
13  2019 Predictors of Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis. IL, sJIA
14  2019 Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma. ---
15  2019 [Transition of treatment strategy for locally advanced rectal cancer towards "watch and wait"]. LARC, TNT
16  2018 'Watch and wait' in rectal cancer: summary of the current evidence. nCRT, pCR, RCTs
17  2018 Clinical and photobiological response in eight patients with solar urticaria under treatment with omalizumab, and review of the literature. DLQI, SU, UAS7, VAS
18  2018 Human papillomavirus infection mediates response and outcome of vulvar squamous cell carcinomas treated with radiation therapy. CRT, HPV, pCR, VC, VSCC
19  2018 Is neoadjuvant chemoradiation with dose-escalation andconsolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baselinecT3 rectal cancer? nCRT, RT
20  2018 Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. IWWD
21  2018 Low neutrophil-lymphocyte ratio correlates with extended survival in patients with metastatic breast cancer who achieved clinically complete response following multidisciplinary therapy: A retrospective study. MBC, NLRs
22  2018 Survey results of US radiation oncology providers' contextual engagement of watch-and-wait beliefs after a complete clinical response to chemoradiation in patients with local rectal cancer. CRT, LARC, ROs
23  2017 Can we predict chemotherapy response in patients with metastatic testicular cancer? Role of thrombocytosis as a novel marker. BEP, CPR, CR, GCT, PCR
24  2017 Concurrent chemoradiation versus radiotherapy alone for the treatment of locally advanced cervical cancer in a low-resource setting. CCRT, EBRT
25  2017 E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group. HPV, IC, IMRT, OPSCC
26  2017 Nonoperative Management or 'Watch and Wait' for Rectal Cancer with Complete Clinical Response After Neoadjuvant Chemoradiotherapy: A Critical Appraisal. nCRT, NOM, PRISMA
27  2017 Rectal sparing approach after preoperative radio- and/or chemotherapy (RESARCH) in patients with rectal cancer: a multicentre observational study. RESARCH
28  2016 CD30+ Cutaneous T Cell Lymphoma: Response to Rotational Total Skin Electron Irradiation. CTCL, OS, RFS, RTSEI
29  2016 Complete Response after Chemoradiotherapy in Rectal Cancer (Watch-and-Wait): Have we Cracked the Code? ---
30  2016 Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer. EGFR, pCR, TNBC
31  2016 Radiation Therapy for Primary Cutaneous Anaplastic Large Cell Lymphoma: An International Lymphoma Radiation Oncology Group Multi-institutional Experience. RT
32  2016 Utility of rectoscopy in the assessment of response to neoadjuvant treatment for locally advanced rectal cancer. ---
33  2015 Nonoperative management of rectal cancer after chemoradiation opposed to resection after complete clinical response. A comparative study. CRT, DFS, DR, LR, NOM, OS, pCR
34  2015 Surveillance after neoadjuvant therapy in advanced rectal cancer with complete clinical response can have comparable outcomes to total mesorectal excision. CEA, CPR, CRT
35  2015 Total skin electron therapy for cutaneous T-cell lymphoma using a modern dual-field rotational technique. CTCL, OS, RFS, RTSEI
36  2015 Vismodegib for Locally Advanced Basal Cell Carcinoma: Descriptive Analysis of a Case Series and Comparison to the Literature. DFS, laBCC, PCR
37  2015 Watch and wait approach to rectal cancer: A review. ---
38  2014 Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. CRT
39  2014 Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact. CI, EGFR, pCR, TNBC
40  2014 Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer. LARC, MSKCC, pathCR, TME
41  2014 Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging. CRT, pCR, PET/CT, SUV
42  2014 The spectrum of pathological changes in breast cancer following neoadjuvant chemotherapy. NAT
43  2013 CA-125-indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery. CRS
44  2013 Complete clinical response to neoadjuvant chemoradiation in rectal cancers: can surgery be avoided? ---
45  2013 Histopathologic changes following neoadjuvant chemotherapy in locally advanced breast cancer. CEF, pCR
46  2013 Is neck dissection necessary after induction plus concurrent chemoradiotherapy in complete responder head and neck cancer patients with pretherapy advanced nodal disease? IC/CCRT, PND
47  2013 Is there a role for surgery for patients with a complete clinical response after chemoradiation for esophageal cancer? An intention-to-treat case-control study. CI, CRT, EC
48  2013 Targeting therapy for esophageal cancer in patients aged 70 and over. AC, naCRT, naCRT, pCR, SCC
49  2012 A single-centre experience of chemoradiotherapy for rectal cancer: is there potential for nonoperative management? CPR, CRT
50  2012 Clinical efficacy of cardiac resynchronization therapy with an implantable defibrillator in a Japanese population: results of the MIRACLE-ICD outcome measured in Japanese indication (MOMIJI) study. CRT, CRT-D, MIRACLE-ICD, MOMIJI, QOL
51  2012 Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056). MF, PR, PUVA, PUVA
52  2012 Long-term outcome of local excision after complete pathological response to neoadjuvant chemoradiation therapy for rectal cancer. CRT, LE
53  2012 Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy. CRT, NOM, pCR
54  2012 Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012. MF, PLD, PR, RR
55  2011 Complete clinical response of liver metastasis after chemotherapy: To resect or not? ---
56  2011 Is radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy? EBC, ERT, LRR, NCT
57  2011 [Early stage breast cancer: is exclusive radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?]. EBC, LRR, NCT
58  2010 Complete clinical response to neoadjuvant chemoradiotherapy in patients with rectal cancer: opinions of British and Irish specialists. ---
59  2010 Late-onset hemorrhagic cystitis in children after hematopoietic stem cell transplantation for thalassemia and sickle cell anemia: a prospective evaluation of polyoma (BK) virus infection and treatment with cidofovir. ATG, CDV, CI, HC, HR, HSCT
60  2010 Neoadjuvant chemo-radiotherapy and rectal cancer: can the UK watch and wait with Brazil? CRT
61  2009 Platin-based exclusive chemotherapy for selected patients with squamous cell carcinoma of the larynx and pharynx. EC
62  2009 WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study. cl
63  2008 Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? CEA, CLM, CPR
64  2008 Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome? CRT
65  2008 Prospective phase II study of brachytherapy boost as a component of neo-adjuvant chemotherapy and external beam radiation therapy in locally advanced rectal cancer. BT, cPR, EBRT, Ir-192, LAR, pCR, pPR
66  2006 Assessment and management of the complete clinical response of rectal cancer to chemoradiotherapy. ---
67  2005 Preoperative chemoradiation for locally advanced carcinoma of the vulva. 5-FU, cPR, GOG
68  2004 An open trial of climatotherapy at the Dead Sea for patch-stage mycosis fungoides. CDS
69  2002 The surgical management of patients following neoadjuvant chemotherapy for locally advanced breast cancer. pCR
70  2001 Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma: preliminary results. Hb
71  1999 Second-line chemotherapy with cisplatin-ifosfamide in patients with ovarian cancer previously treated with carboplatin-cyclophosphamide. CNS, PR
72  1997 The effect of prolonged cycles of chemotherapy on quality of life in gynaecologic cancer patients. EWB, FACT-G, FWB, PWB, QOL, RWD, SWB
73  1997 Ultrasound assessment of residual abnormalities following primary chemotherapy for breast cancer. PMT, US
74  1996 Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results. EC, IC
75  1996 Extent of skin involvement as a prognostic indicator of disease free and overall survival of patients with T3 cutaneous T-cell lymphoma treated with total skin electron beam radiation therapy. CTCL, DFS, ESI, Gy, OS, TSEBT
76  1993 Long-term follow-up of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and possible postoperative radiotherapy and/or chemotherapy in squamous cell carcinoma of the esophagus. PCR
77  1991 A pilot study of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and postoperative radiation therapy and/or chemotherapy in adenocarcinoma of the esophagus. 5-FU, PCR
78  1991 [Induction chemotherapy with cisplatin and 5-FU in locally advanced head and neck cancer. Study of 2 administration schedules]. ---